This announcement is a separate document:
中天运会计师事务所（特殊普通合伙）关于江苏诺泰澳赛诺生物制药股份有限公司2023年年报问询函回复的核查意见
Inspection opinions of Zhongtianyun Certified Public Accountants (Special General Partnership) on the response to the inquiry letter on the 2023 annual report of Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.